The group’s principle activities include discovering and developing novel human antibody therapeutics for treatment of infectious disease. The group operates from United States.
Executive Information
Name
Title
Email
Brian Cunningham
Dir., CEO, Pres.
N/A
Bruce Keyt
CTO, VP - Research
N/A
Lawrence Kauvar
Founder, Sr. VP, Chief Scientific Officer
N/A
Stote Ellsworth
COO, VP
N/A
John Wulf
Exec. VP - Business Operations, Chief Business Officer
